IMMUNE DESIGN CORP.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$141.6M

388 transactions

Summary

IMMUNE DESIGN CORP. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $72.5MSales: $27.9M42 insiders

Date	Insider	Type	Value
2019-04-02	COLEMAN LEWIS W	D	$1.0M
2019-04-02	COLEMAN LEWIS W	D	$18K
2019-04-02	COLEMAN LEWIS W	D	—
2019-04-02	COLEMAN LEWIS W	D	—
2019-04-02	COLEMAN LEWIS W	D	—
2019-04-02	RINGO WILLIAM R	D	—
2019-04-02	RINGO WILLIAM R	D	—
2019-04-02	RINGO WILLIAM R	D	—
2019-04-02	PENHOET EDWARD	D	—
2019-04-02	PENHOET EDWARD	D	—
2019-04-02	PENHOET EDWARD	D	—
2019-04-02	PENHOET EDWARD	D	—
2019-04-02	PENHOET EDWARD	D	—
2019-04-02	Kelley Susan L.	D	—
2019-04-02	Kelley Susan L.	D	—
2019-04-02	Kelley Susan L.	D	—
2019-04-02	ter Meulen Jan Henrik(Chief Scientific Officer)	D	—
2019-04-02	ter Meulen Jan Henrik(Chief Scientific Officer)	D	—
2019-04-02	ter Meulen Jan Henrik(Chief Scientific Officer)	D	—
2019-04-02	ter Meulen Jan Henrik(Chief Scientific Officer)	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

IMMUNE DESIGN CORP. — Contributions, Lobbying & Contracts | Poliscope